Saidutta Nanda joins Ipca Labs as President - Human Resources

Published On 2025-03-04 08:00 GMT | Update On 2025-03-04 08:00 GMT

Mumbai: Ipca Labs has announced the appointment of Saidutta Nanda as President - Human Resources.

"This is to inform you that Saidutta Nanda has joined the Company as President – Human Resources with effect from 3rd March, 2025," the Company stated in a BSE filing.

He will be responsible for leading all the activities related to the Human Resources Division of the Company. He is not related to any Director or Key Managerial Personnel of the Company.

Saidutta Nanda, aged 48 years, brings with him a professional experience of over 24 years. He started his career with Cadila Pharmaceuticals in the year 1999. Prior to joining Ipca, he was associated with Macleods Pharmaceuticals Limited as President - Human Resources.

Nanda has completed his Master of Business Administration from Institute of Management Studies, Devi Ahilya Vishwavidyalay, Indore.

Established in 1949, lpca is a pharmaceutical company. lpca is vertically integrated and produces finished dosage forms and active pharmaceutical ingredients. For more than 70 years, lpca has been a crucial healthcare partner in over 120 countries across the globe. lpca markets its branded formulations in India and rest of the world markets and generic formulations in United States, Europe, United Kingdom, Canada, Australia & New Zealand. APls manufactured by lpca are marketed across the globe.

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Saidutta Nanda joins Ipca Labs as President - Human Resources

Similar News

FSSAI Bar on Dr Reddy's Nutraceutical Put on Hold: Delhi HC Awaits Regulatory Hearing Outcome

Doctors Slam FSSAI Inaction After Delhi HC Allows ORSL Sales, Warn of Child Health Risks

India deepens anti dumping probe into imports of anti TB drug ingredient from China, Thailand

Indian pharma, healthcare sector record 72 deals worth USD 3.5 billion in Q3 2025: Grant Thornton Bharat

Thermo Fisher Scientific inaugurates expanded RnD Centre of Excellence in Bengaluru

Pulse Pharma Gets CDSCO Panel Nod to Manufacture, Market Aripiprazole Oral Solution

Maha: Rs 14-Crore Mephedrone Unit Busted Near Police Station, Cop Suspended for Negligence

MP FDA Moves Rs 320-Crore Proposal to CDSCO, FSSAI to Upgrade Drug, Food Testing Labs